A detailed history of Premier Fund Managers LTD transactions in United Therapeutics Corp stock. As of the latest transaction made, Premier Fund Managers LTD holds 14,800 shares of UTHR stock, worth $5.38 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
14,800
Holding current value
$5.38 Million
% of portfolio
0.19%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$311.04 - $363.55 $4.6 Million - $5.38 Million
14,800 New
14,800 $5.31 Million
Q1 2023

May 05, 2023

SELL
$212.99 - $276.17 $638,970 - $828,510
-3,000 Reduced 12.5%
21,000 $4.6 Million
Q4 2022

Feb 09, 2023

BUY
$205.95 - $280.43 $1.85 Million - $2.52 Million
9,000 Added 60.0%
24,000 $6.62 Million
Q4 2022

Feb 08, 2023

BUY
$205.95 - $280.43 $3.09 Million - $4.21 Million
15,000 New
15,000 $13,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.5B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Premier Fund Managers LTD Portfolio

Follow Premier Fund Managers LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Premier Fund Managers LTD, based on Form 13F filings with the SEC.

News

Stay updated on Premier Fund Managers LTD with notifications on news.